Copyright
©The Author(s) 2021.
World J Diabetes. Dec 15, 2021; 12(12): 1979-1999
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.1979
Published online Dec 15, 2021. doi: 10.4239/wjd.v12.i12.1979
Ref. | Treatment | Animal model | Main findings |
[1] | Taohong Siwu decoction 18, 9 and 4.5mg/kg | Rat with middle cerebral artery occlusion | Improved neubehavioral function and inflammation and inhibited pyroptosis following ischemic stroke |
Intragastric administration for 7 d | |||
[2] | Z-Guggulsterone, 12.5, 25, 50 mg/kg, (ip) | Rat with middle cerebral artery occlusion | Z-Guggulsterone improved neurological deficit and, modulated redox imbalance and inflammation through inhibition of TXNIP/NLRP3 signaling |
Intraperitoneal administration for 6 d | |||
[11] | Curcumin 50 mg/kg, | Rat with cerebral artery occlusion | Attenuated ischemic brain injury. Modulation of TXNIP/NLRP3 inflammasome activation by suppression of ER stress. |
One hour before surgery, (ip) | |||
[70] [69] | Curcumin | HFD/ High sugar diet | Prevented fatty liver via inhibition of TXNIP |
[66] | Qurecetin | diabetes | Prevented inflammation, liver TXNIP, lipid accumulation |
[6] | Ketogenic diet | Mouse model of middle cerebral artery occlusion | Ketogenic diet improved ischemic tolerance, Attenuated ER stress and TXNIP/NLRP3 activation |
3 wk | |||
[7] | Umbelliferone, 15and 30 mg /kg | Rat with middle cerebral artery occlusion | Protected against cerebral ischemia reperfusion injury by suppressing TXNIP/NLRP3 inflammasome activation |
Pretreatment for 7 d (ip) | |||
[8] | Ruscogenin, 10 mg/kg One hour before surgery, (Intra gastic admin. | Mice with middle cerebral artery occlusion | Decreased brain infarction, edema, improved neurological outcome by suppressing a TXNIP/NLRP3 inflammasome activation and MAPK pathway |
[9] | Resveratrol, 5 mg/Kg | WT mice with embolic middle cerebral artery occlusion | Protected from ischemic injury, improved neurological score suppressed TXNIP/NLRP3 inflammasome and apoptosis |
3 h post-embolic occlusion. (iv) | |||
[21] | Salvianolic acid | HFD- Rats | Prevented HFD-induced NAFLD |
[65] | Salidroside | Prevented HFD-induced NAFLD | |
[12] | Compound 10b, 3 mg/kg | Rat with middle cerebral artery occlusion | Attenuated cerebral ischemia by upregulating endogenous antioxidant system and down regulation of oxidative stress. |
At the onset of reperfusion |
- Citation: Mohamed IN, Li L, Ismael S, Ishrat T, El-Remessy AB. Thioredoxin interacting protein, a key molecular switch between oxidative stress and sterile inflammation in cellular response. World J Diabetes 2021; 12(12): 1979-1999
- URL: https://www.wjgnet.com/1948-9358/full/v12/i12/1979.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i12.1979